Showing results (601-610 of 911) with videos related to
Sort By:
Pageof 92
The Lancet. Psychiatry|July 15, 2018
Internet-based behavioural activation with lay counsellor support versus online minimal psychoeducation without support for treatment of depression: a randomised controlled trial in IndonesiaRetha Arjadi, Maaike H Nauta, Willem F Scholte, et al.The Lancet. Psychiatry|September 22, 2016
Epidemiology of maternal depression, risk factors, and child outcomes in low-income and middle-income countriesBizu Gelaye, Marta B Rondon, Ricardo Araya, et al.The Lancet. Psychiatry|May 1, 2017
Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general populationDeborah S Hasin, Melanie Wall, Katie Witkiewitz, et al.The Lancet. Psychiatry|June 20, 2017
Mental health in Zimbabwe: a health systems analysisKhameer Kidia, Debra Machando, Walter Mangezi, et al.The Lancet. Psychiatry|May 13, 2017
A blind spot on the global mental health map: a scoping review of 25 years' development of mental health care for people with severe mental illnesses in central and eastern EuropePetr Winkler, Dzmitry Krupchanka, Tessa Roberts, et al.The Lancet. Psychiatry|June 29, 2020
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance studyAravinthan Varatharaj, Naomi Thomas, Mark A Ellul, et al.The Lancet. Psychiatry|July 17, 2022
Sub-national patterns and correlates of depression among adults aged 45 years and older: findings from wave 1 of the Longitudinal Ageing Study in IndiaArokiasamy Perianayagam, Matthew Prina, Y Selvamani, et al.The Lancet. Psychiatry|May 19, 2023
The relationship between cannabis use, schizophrenia, and bipolar disorder: a genetically informed studyWeiqiu Cheng, Nadine Parker, Naz Karadag, et al.The Lancet. Psychiatry|February 21, 2023
Predicting psychotic relapse following randomised discontinuation of paliperidone in individuals with schizophrenia or schizoaffective disorder: an individual participant data analysisLasse Brandt, Kerstin Ritter, Johannes Schneider-Thoma, et al.The Lancet. Psychiatry|March 23, 2023
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) studyKenneth K C Man, Alexander Häge, Tobias Banaschewski, et al.Pageof 92